Familial acromegaly
Showing 1 - 25 of 1,023
Genetics of Endocrine Tumours - Familial Isolated Pituitary
Recruiting
- Acromegaly
- +5 more
-
London, United Kingdom
- +1 more
Oct 17, 2022
Pituitary Tumors and Related Hypothalmic Disorders
Recruiting
- Panhypopituitarism
- +3 more
- MRI
- Tissue specimen collection
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Pituitary Tumours: Prevalence of Associated Neoplasia
Recruiting
- Pituitary Tumor
- +4 more
- Registration of familial forms and associated neoplasia
-
Pozzilli, IS, ItalyNeuromed
Aug 31, 2021
Epicardial Fat Thickness in Children With Familial Dyslipidemia
Not yet recruiting
- Dyslipidemia
- echoCARDIOGRAPHY
- (no location specified)
Oct 22, 2023
Somatostatin Receptors and GH Receptor Expression on Bone of
Completed
- Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
- Trans-sphenoidal surgery
-
Roma, ItalyFondazione Policlinnico Gemelli IRCCS
Apr 6, 2023
Family Status of Osteopathic Medical Students on Their Perceived
Completed
- Stress, Psychological
- Survey
-
New York, New YorkTouro College of Osteopathic Medicine
Sep 14, 2023
Therapies in Acromegaly Disease: Acral Morpho-functional Study
Recruiting
- Acromegaly
- Medical surgery therapy
-
Milano, ItalyIstituto Auxologico Italiano IRCCS San Luca
Jul 25, 2023
Acromegaly Due to Pituitary Adenoma Trial in Copenhagen (GIP-A, Placebo)
Recruiting
- Acromegaly Due to Pituitary Adenoma
- GIP-A
- Placebo
-
Copenhagen, DenmarkDepartment of Biomedical Sciences
Nov 1, 2022
FMF Trial in Istanbul (video game group, Education booklet group)
Recruiting
- FMF
- video game group
- Education booklet group
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Jul 31, 2023
Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)
Terminated
- Acromegaly
- Pegvisomant
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 12, 2022
Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)
Recruiting
- Acromegaly
- GEP-NET
- Debio 4126
- +2 more
-
Copenaghen, Denmark
- +34 more
Jan 27, 2023
(RWS) of Lanreotide Autogel for Treatment of Acromegaly in China
Recruiting
- Acromegaly
-
Beijing, China
- +11 more
Jul 13, 2022
Acromegaly Trial in Worldwide (CAM2029 (octreotide subcutaneous depot), Matching )
Active, not recruiting
- Acromegaly
- CAM2029 (octreotide subcutaneous depot)
- Matching placebo
-
Los Angeles, California
- +62 more
Dec 9, 2022
Acromegaly: Balance, Falls and Fracture Risk
Not yet recruiting
- Acromegaly
- HR-pQCT
- +7 more
-
Aalborg, North Denmark Region, DenmarkAalborg University Hospital
Mar 3, 2023
Homozygous Familial Hypercholesterolemia Trial (SHR-1918)
Not yet recruiting
- Homozygous Familial Hypercholesterolemia
- (no location specified)
Aug 22, 2023
PegvisOMant and the Immune SystEm (PROMISE)
Active, not recruiting
- Acromegaly
-
Rome, ItalyDepartment of Experimental Medicine, "Sapienza" University of Ro
Nov 6, 2022
Familial Hyperlipidemia Trial
Not yet recruiting
- Familial Hyperlipidemia
- (no location specified)
Apr 12, 2023
Acromegaly Trial (Diet)
Not yet recruiting
- Acromegaly
- Diet
- (no location specified)
Jul 18, 2022
Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)
Not yet recruiting
- Homozygous Familial Hypercholesterolemia
- NGGT006
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023
A Prospective Study of Outcome After Therapy for Acromegaly
Active, not recruiting
- Acromegaly
- Surgery for acromegaly
- +3 more
-
New York, New YorkNeuroendocrine Unit; Columbia University Medical Center, 180 For
Oct 24, 2022
Satisfaction With Somatostatin Analogue Injections in Acromegaly
Not yet recruiting
- Acromegaly
- (no location specified)
Aug 9, 2022
Coronary Artery Disease Progression Trial in Amsterdam
Recruiting
- Coronary Artery Disease Progression
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Mar 23, 2023
Lipid Metabolism Disorder Trial (Implementation Strategy Bundle, Usual care notification)
Not yet recruiting
- Lipid Metabolism Disorder
- Implementation Strategy Bundle
- Usual care notification
- (no location specified)
Jan 11, 2023